There is no single medical definition that marks a bright line between short-term and long-term insulin use. In practice, most clinicians consider insulin therapy “long-term” once it extends beyond six months to a year with no plan to discontinue. For many people with diabetes, insulin becomes a permanent part of life, making the real question less about a specific cutoff and more about what years of insulin therapy mean for your body, your risks, and your daily routine.
Why Some People Use Insulin Temporarily and Others Use It for Life
The distinction between temporary and long-term insulin use comes down to why you need it in the first place. In type 1 diabetes, the immune system destroys the cells in the pancreas that produce insulin, leading to a progressive and irreversible decline in production. People with type 1 diabetes require insulin for survival from diagnosis onward, making their use lifelong by definition.
Type 2 diabetes follows a different trajectory. Early on, the pancreas still makes insulin but the body doesn’t use it efficiently. Oral medications, diet changes, and exercise can often manage blood sugar for years. But beta cells (the insulin-producing cells) slowly deteriorate over time, and many people with type 2 diabetes eventually need insulin to maintain adequate blood sugar control. Once that transition happens, it tends to be permanent, though some people who lose significant weight or undergo metabolic surgery can reduce or stop insulin.
There are also genuinely short-term uses: gestational diabetes during pregnancy, a hospital stay for surgery or acute illness, or a brief course to bring dangerously high blood sugar under control before switching to other medications. In these cases, insulin might last days to a few months. When insulin stretches past that window and becomes part of your ongoing treatment plan, you’re in long-term territory.
Weight Changes After Starting Insulin
Weight gain is one of the most common concerns people have about staying on insulin, and the data confirms it’s real but usually modest. An international study of over 2,100 people with type 2 diabetes newly starting insulin (the CREDIT study) found an average weight gain of about 1.8 kilograms (roughly 4 pounds) after one year. The UK Prospective Diabetes Study found a similar figure of around 2 to 2.5 kilograms in the first year. About one in four people in the CREDIT study gained 5 kilograms (11 pounds) or more, so the range varies considerably from person to person.
Several factors predicted more weight gain: higher blood sugar levels at baseline, higher insulin doses, and a lower starting BMI. The weight gain was similar for men and women. Over multiple years, weight can continue to creep up, which is one reason clinicians monitor dosing carefully and often pair insulin with lifestyle strategies or medications that offset the effect. If you’ve noticed gradual weight gain since starting insulin, you’re experiencing something common, not a sign that something is going wrong with your treatment.
Hypoglycemia Unawareness Over Time
Low blood sugar (hypoglycemia) is a known risk of insulin therapy at any stage, but the longer you use insulin, the more likely you are to develop a particularly tricky complication: hypoglycemia unawareness. Normally, when blood sugar drops too low, your body sends warning signals like shakiness, sweating, and a racing heart. With hypoglycemia unawareness, those warning signs fade or disappear, and the first symptoms you notice are confusion, difficulty thinking, or even loss of consciousness.
This affects roughly 40% of people with type 1 diabetes and occurs less frequently in type 2, particularly in those whose own insulin production has declined significantly. The major risk factors are duration of the disease and a history of frequent low blood sugar episodes. Tight blood sugar control, which is the goal of insulin therapy, paradoxically raises the risk because repeated mild lows train the brain to stop sounding the alarm. Older age also increases susceptibility.
For people who have been on insulin for a decade or more, this is worth discussing with a healthcare provider. Continuous glucose monitors have become a practical tool for catching lows before they become dangerous, especially for people who can no longer rely on their body’s own warning system.
Cardiovascular Risk With Prolonged Insulin Use
The relationship between long-term insulin therapy and heart health is one of the more debated topics in diabetes care. Several large observational studies have found dose-dependent associations between injected insulin and increased cardiovascular risk and mortality in people with type 2 diabetes. That means higher insulin doses correlated with higher rates of heart attacks, strokes, and death from cardiovascular causes.
This does not necessarily mean insulin itself causes heart disease. People who need insulin typically have more advanced diabetes, more difficulty controlling blood sugar, and more existing risk factors. Separating the effect of the drug from the severity of the disease it’s treating is extremely difficult. Still, the pattern has prompted researchers to note that insulin therapy appears to have a less favorable long-term safety profile compared to some other type 2 diabetes treatments when cardiovascular outcomes are the measure. For people with type 1 diabetes, there is no alternative to insulin, so the calculation is different entirely.
If you have type 2 diabetes and have been on insulin for years, this data doesn’t mean you should stop. It does mean that regular cardiovascular monitoring, blood pressure management, and cholesterol control matter even more as part of your overall care.
The Psychological Side of Long-Term Injections
Living with daily injections for years takes a psychological toll that often goes unrecognized. A study developing a measurement tool for injection-related distress surveyed patients who had been injecting insulin for an average of about 11 years. The biggest sources of distress were surprisingly practical: the burden of carrying injection supplies, the hassle of finding and rotating injection sites, and the discomfort of injecting in public where others might stare.
Beyond these daily frustrations, longer-term users reported that insulin injections limited their ability to participate in physical activities, travel freely, eat out at restaurants, and engage in hobbies or social events. Workplace concerns and fear of being judged added another layer. These aren’t minor inconveniences. Over years, they compound into a persistent background stress that can affect quality of life and, in some cases, lead people to skip doses or reduce their insulin without medical guidance.
Newer delivery options like insulin pens and pumps have reduced some of this friction compared to traditional syringes. If the logistics of injections are wearing you down after years of use, that’s a legitimate concern to raise, not something to push through silently.
What Changes After 5, 10, or 20 Years
The practical reality of insulin therapy shifts as the years accumulate. In the first year or two, you’re learning the mechanics: timing, dosing, recognizing lows, adjusting for meals and exercise. After five years, the routine is usually second nature, but you may notice that your doses have gradually increased as your body’s own insulin production continues to decline (in type 2) or as insulin resistance changes with age and weight.
By the 10-year mark, hypoglycemia unawareness becomes a more pressing concern, and the cumulative effects on weight and cardiovascular health deserve closer attention. Injection site complications, like lipohypertrophy (lumpy fatty tissue that forms from repeated injections in the same spot), become more common and can actually interfere with insulin absorption if sites aren’t rotated carefully.
After 20 years or more, many people with type 1 diabetes are managing a complex regimen that may include a pump, a continuous glucose monitor, and careful coordination with other medications for complications like kidney changes or nerve damage. For type 2 diabetes, decades on insulin often reflect a disease that has progressed through multiple treatment stages. At every point along this timeline, the goal remains the same: keeping blood sugar controlled enough to prevent complications while minimizing the side effects of the therapy itself.